WHO ICTRP trial
Carnitine for the Treatment of Fatigue in Multiple Sclerosis
IRCT2012092010891N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2012092010891N1 |
|---|---|
| Public title | Carnitine for the Treatment of Fatigue in Multiple Sclerosis |
| Scientific title | comparison of Carnitine with placebo for the Treatment of Fatigue in Patients with Multiple Sclerosis in a Randomized Double-blind Clinical Trial |
| Primary sponsor | Isfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Multiple Sclerosis. Multiple sclerosis;Multiple sclerosis |
| Interventions | Intervention 1: intervention group: carnitine 1000mg/d for 8 weeks (tab 500mg, bid). Intervention 2: control: placebo for 8 weeks.;Treatment - Drugs;Treatment - Drugs;intervention group: carnitine 1000mg/d for 8 weeks (tab 500mg… |
| Registration date | Dec 23, 2014 |
| Target size | 67 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: